Cargando…
Immune Response to COVID-19: Can We Benefit from the SARS-CoV and MERS-CoV Pandemic Experience?
The global range and high fatality rate of the newest human coronavirus (HCoV) pandemic has made SARS-CoV-2 the focus of the scientific world. Next-generation sequencing of the viral genome and a phylogenetic analysis have shown the high homology of SARS-CoV-2 to other HCoVs that have led to local e...
Autores principales: | Sinderewicz, Emilia, Czelejewska, Wioleta, Jezierska-Wozniak, Katarzyna, Staszkiewicz-Chodor, Joanna, Maksymowicz, Wojciech |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7559562/ https://www.ncbi.nlm.nih.gov/pubmed/32916812 http://dx.doi.org/10.3390/pathogens9090739 |
Ejemplares similares
-
Influence of Bone Marrow-Derived Mesenchymal Stem Cell Therapy on Oxidative Stress Intensity in Minimally Conscious State Patients
por: Jezierska-Wozniak, Katarzyna, et al.
Publicado: (2020) -
MERS-CoV
por: Müller, Marcel A
Publicado: (2014) -
The epidemiology of MERS-CoV
por: Fisman, David N, et al.
Publicado: (2014) -
MERS-CoV spike nanoparticles protect mice from MERS-CoV infection
por: Coleman, Christopher M., et al.
Publicado: (2017) -
MERS-CoV Infection of Alpaca in a Region Where MERS-CoV is Endemic
por: Reusken, Chantal B.E.M., et al.
Publicado: (2016)